Auckland-based startup Ubiquitome has become the first Kiwi company to receive funding from the United States government-funded medical research centre National Institutes of Health (NIH) for its rapid Covid-19 testing device.
The amount Ubiquitome received remains confidential, but chief
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
